4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-036054
EVP, Chief Medical Officer sold 2,042 shares at $17.04 ($34,792)
From the SEC's structured data for this filing
Trades in this filing
Eisner Mark · EVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Sale : show line 1 in the form | −2,042 | $17.04 | $34,792 | 162,862 | D |
| Open-market sales · 2,042 sh · avg $17.04 · $34,792 | ||||||
Loading xslF345X04/doc4.xml…